DOCSLIB.ORG

T Cell Clones +CD8 Functional Diversity in Melanoma-Specific

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
T Cell Clones +CD8 Functional Diversity in Melanoma-Specific Trogocytosis Is a Gateway to Characterize Functional Diversity in Melanoma-Specific CD8+ T Cell Clones This information is current as Ronny Uzana, Galit Eisenberg, Yael Sagi, Shoshana of October 2, 2021. Frankenburg, Sharon Merims, Ninette Amariglio, Eitan Yefenof, Tamar Peretz, Arthur Machlenkin and Michal Lotem J Immunol 2012; 188:632-640; Prepublished online 7 December 2011; doi: 10.4049/jimmunol.1101429 Downloaded from http://www.jimmunol.org/content/188/2/632 Supplementary http://www.jimmunol.org/content/suppl/2011/12/07/jimmunol.110142 http://www.jimmunol.org/ Material 9.DC1 References This article cites 50 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/188/2/632.full#ref-list-1 Why The JI? Submit online. by guest on October 2, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Trogocytosis Is a Gateway to Characterize Functional Diversity in Melanoma-Specific CD8+ T Cell Clones Ronny Uzana,* Galit Eisenberg,* Yael Sagi,† Shoshana Frankenburg,* Sharon Merims,* Ninette Amariglio,‡ Eitan Yefenof,x Tamar Peretz,* Arthur Machlenkin,*,1 and Michal Lotem*,1 Trogocytosis, the transfer of membrane patches from target to immune effector cells, is a signature of tumor–T cell interaction. In this study, we used the trogocytosis phenomenon to study functional diversity within tumor-specific T cell clones with identical TCR specificity. MART-126–35–specific CD8 T cell clones, which differed in their trogocytosis capacity (low [2D11], intermediate [2G1], high [2E2]), were generated from melanoma patients. Functional evaluation of the clones showed that the percentage of trogocytosis-capable T cells closely paralleled each clone’s IFN-g and TNF-a production, lysosome degranulation, and lysis of peptide-pulsed targets and unmodified melanoma. The highly cytotoxic 2E2 clone displayed the highest TCR peptide binding Downloaded from affinity, whereas the low-activity 2D11 clone showed TCR binding to peptide-MHC in a CD8-dependent manner. TCR analysis revealed Vb16 for clones 2E2 and 2G1 and Vb14 for 2D11. When peptide-affinity differences were bypassed by nonspecific TCR stimulation, clones 2E2 and 2D11 still manifested distinctive signaling patterns. The high-activity 2E2 clone displayed prolonged phosphorylation of ribosomal protein S6, an integrator of MAPK and AKT activation, whereas the low-activity 2D11 clone generated shorter and weaker phosphorylation. Screening the two clones with identical TCR Vb by immunoreceptor array showed higher phosphorylation of NK, T, and B cell Ag (NTB-A), a SLAM family homophilic receptor, in clone 2E2 compared http://www.jimmunol.org/ with 2G1. Specific blocking of NTB-A on APCs markedly reduced cytokine production by CD8 lymphocytes, pointing to a possible contribution of NTB-A costimulation to T cell functional diversity. This finding identifies NTB-A as a potential target for improving anti-cancer immunotherapy. The Journal of Immunology, 2012, 188: 632–640. ytotoxic CD8+ T cells specific for a single antigenic (pMHC) not only determines the activation capacity of the for- epitope can originate from one or several progenitors, mer, but also that of its clonal progeny (6). Short and loose C distinguishable by their TCR sequences (1). The structure interactions yield subclones of low potency whereas long and tight of the TCR is the major determinant of T cell functional robust- contact results in highly reactive T cells, thus leading to clonal ness, specifying its binding affinity to a cognate peptide presented diversity (2, 7). Although the mechanism underlying the func- by guest on October 2, 2021 by an appropriate MHC class I molecule (2). In vivo, many other tional imprint of T cells is not yet fully elucidated, it is clear that factors affect the actual cytotoxic capacity of T cells, including in addition to TCR affinity, other interactions take place at the their state of differentiation, shifting from naive cells to terminally initial immunological synapse, which shape T cell functional ca- differentiated effectors, length of activation (3), cytokine milieu pacity. Immunological synapse refers to the focal contact between (4), and costimulation (5). Hence, T cell competence reflects the an immune effector cell and APCs. It is a contact-secretion pro- overall outcome of all these variables. cess that leads to effector cell activation by reciprocal molecular Recently, it has been acknowledged that the initial encoun- clustering of ligands and receptors on the cytoplasmic membranes ter between a naive CD8+ T cell with its cognate peptide-MHC of the cellular partners involved (8, 9). The linkage between receptors and ligands leads to the unidirectional transfer of mem- brane fragments from APCs to effector cells, a process termed *Sharett Institute of Oncology, Hadassah Medical Organization, Jerusalem 91120, Israel; †Division of Oncology, School of Medicine, Stanford University, Stanford, CA “trogocytosis” (10–12). It is readily visible by labeling Ag-loaded 94305; ‡Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan 52621, x APCs with a membrane dye that can be detected on cognate Israel; and Lautenberg Center for General and Tumor Immunology, Hebrew T cells by immunofluorescence (13). Thus, trogocytosis provides University of Jerusalem, Jerusalem 91120, Israel a useful signature for T cells that have interacted with APCs. 1A.M. and M.L. share senior authorship of this work. We have previously shown that trogocytosis also occurs between Received for publication May 16, 2011. Accepted for publication November 2, 2011. tumor-reactive CD8+ T cells and melanoma target cells (14), and This work was supported by the Israel Cancer Association, the Chief Scientist of that it is preferentially associated with a highly cytotoxic T cell the Israel Ministry of Health, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. population. Notably, TCR specificity was not the only determinant Address correspondence and reprint requests to Dr. Arthur Machlenkin and Dr. of trogocytosis, as a proportion of Ag-specific T cells with the Michal Lotem, Sharett Institute of Oncology, Hadassah Medical Organization, P.O. same TCR specificity did not capture target membranes. In the Box 12000, Jerusalem 91120, Israel. E-mail addresses: [email protected] present study, we aim to elucidate the reasons for the functional (A.M.) and [email protected] (M.L.) diversity within CD8+ T cells with the same TCR specificity. The online version of this article contains supplemental material. Abbreviations used in this article: LCK, lymphocyte-specific protein tyrosine kinase; NTB-A, NK, T, and B cell Ag; PLC, phospholipase C; pMHC, peptide-MHC; rhIL-2, Materials and Methods recombinant human IL-2; SLP-76, Src homology 2 domain-containing leukocyte Tumor cell lines and lymphocyte cultures protein of 76 kDa; TIL, tumor-infiltrating lymphocyte. Melanoma cell line M171 (HLA-A22/MART-1+) was established in the Copyright Ó 2012 by The American Association of Immunologists, Inc. 0022-1767/12/$16.00 Sharett Institute of Oncology, Hadassah Medical Organization (Jerusalem, www.jimmunol.org/cgi/doi/10.4049/jimmunol.1101429 The Journal of Immunology 633 Israel) (15). 624mel (HLA-A2+/MART-1+) was a gift of M. Parkhurst cells were then harvested, resuspended in FACS buffer, and surface stained (Surgery Branch, National Institutes of Health, Bethesda, MD). T2 is a with fluorophore-conjugated anti-CD8 mAb for 30 min at 4˚C. Following TAP-2–deficient lymphoblastoid line of HLA-A2 genotype. All cell lines permeabilization with Cytofix/Cytoperm buffer, intracellular proteins were were cultured in RPMI 1640 supplemented with 10% heat-inactivated stained with one of the following mAb: anti–IFN-g-PE or -FITC, anti– FCS, 2 mmol/l L-glutamine, and combined antibiotics. Tumor-infiltrat- TNF-a-PE, anti–perforin-PE, anti-granzyme B-PE (all from eBioscience), ing lymphocyte (TIL) microcultures were initiated and expanded from and anti–TCRz-chain-PE (kind gift from M. Baniyash). Appropriate iso- tumor specimens taken from resected metastases of melanoma patients, as type controls were used. The data were analyzed using FCS Express described (16). Human lymphocytes were cultured in complete medium software (De Novo Software, Los Angeles, CA). consisting of RPMI 1640 supplemented with 10% heat-inactivated hu- man AB serum, 6000 IU/ml recombinant human IL-2 (rhIL-2; Chiron, Cytotoxicity assay Amsterdam, The Netherlands), 2 mmol/l L-glutamine, 1 mmol/l sodium In vitro cytotoxicity assays were performed as described (17). Briefly, pyruvate, 1% nonessential amino acids, 25 mmol/l HEPES (pH 7.4), 50 lymphocytes were washed, resuspended in complete medium, and mixed mmol/l 2-ME, and combined antibiotics (all from Invitrogen
Load more

Recommended publications
  • REVIEW Multiple Myeloma: the Cells of Origin – a Two-Way Street
    Leukemia (1998) 12, 121–127 1998 Stockton Press All rights reserved 0887-6924/98 $12.00 REVIEW Multiple myeloma: the cells of origin – A two-way street JR Berenson, RA Vescio and J Said West Los Angeles VA Medical Center, UCLA School of Medicine, Los Angeles, CA, USA Multiple myeloma results from an interplay between the mono- earlier precursor cells may be responsible for the proliferation clonal malignant plasma cells and supporting nonmalignant of the malignant population. The presence of a circulating cells in the bone marrow. Recent studies suggest that the final transforming event in this B cell disorder occurs at a late stage tumor component without obvious plasma cell morphology of B cell differentiation based on the characteristics of the also suggests that less mature lymphocytes may be part of the immunoglobulin genes expressed by the malignant clone as clone as well, which could explain the dissemination of the well as surface markers present on the tumor cells. Recently, disease throughout the bone marrow.4 In addition, evidence an increasing pathogenic role in this malignancy by the nonma- for tumor cells at even earlier stages of hematopoietic differen- lignant cells in the bone marrow has been suggested by several tiation came from studies showing the high rate of acute non- studies. Specific infection of these supporting cells by the lymphoblastic leukemia in these patients and the presence of recently identified Kaposi’s sarcoma-associated herpes virus 5,6 (KSHV) suggests a novel mechanism by which this nonmalig- non-lymphoid surface markers on malignant plasma cells. A nant population may lead to the development of this B cell variety of molecular biological techniques have subsequently malignancy and support its growth.
    [Show full text]
  • How Many Different Clonotypes Do Immune Repertoires Contain?
    How many different clonotypes do immune repertoires contain? Thierry Mora and Aleksandra M. Walczak Laboratoire de physique de l'Ecole´ normale sup´erieure (PSL University), CNRS, Sorbonne Universit´e,and Universit´ede Paris, 75005 Paris, France Immune repertoires rely on diversity of T-cell and B-cell receptors to protect us against foreign threats. The ability to recognize a wide variety of pathogens is linked to the number of different clonotypes expressed by an individual. Out of the estimated ∼ 1012 different B and T cells in humans, how many of them express distinct receptors? We review current and past estimates for these numbers. We point out a fundamental limitation of current methods, which ignore the tail of small clones in the distribution of clone sizes. We show that this tail strongly affects the total number of clones, but it is impractical to access experimentally. We propose that combining statistical models with mechanistic models of lymphocyte clonal dynamics offers possible new strategies for estimating the number of clones. I. INTRODUCTION dent [9, 10]. The total number of different αβ pairs that the generation machinery can produce is much greater The diversity of immune repertoires plays an impor- than the total number of receptors in the whole human tant role in the host's ability to recognize and control population [9, 11, 12]. Thus, each person harbors only a wide range of pathogens. While actual recognition of a small fraction of the potential diversity of receptors. an antigen depends on having a relatively specific T-cell To estimate the number of distinct receptors, we need to or B-cell receptor (TCR or BCR), multiple experimen- count them.
    [Show full text]
  • Early Life Imprints the Hierarchy of T Cell Clone Sizes Mario U Gaimann1,2, Maximilian Nguyen1, Jonathan Desponds3, Andreas Mayer1*
    RESEARCH ARTICLE Early life imprints the hierarchy of T cell clone sizes Mario U Gaimann1,2, Maximilian Nguyen1, Jonathan Desponds3, Andreas Mayer1* 1Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, United States; 2Arnold Sommerfeld Center for Theoretical Physics and Center for NanoScience, Department of Physics, Ludwig-Maximilians-Universita¨ t Mu¨ nchen, Mu¨ nchen, Germany; 3NSF-Simons Center for Quantitative Biology, Northwestern University, Evanston, United States Abstract The adaptive immune system responds to pathogens by selecting clones of cells with specific receptors. While clonal selection in response to particular antigens has been studied in detail, it is unknown how a lifetime of exposures to many antigens collectively shape the immune repertoire. Here, using mathematical modeling and statistical analyses of T cell receptor sequencing data, we develop a quantitative theory of human T cell dynamics compatible with the statistical laws of repertoire organization. We find that clonal expansions during a perinatal time window leave a long-lasting imprint on the human T cell repertoire, which is only slowly reshaped by fluctuating clonal selection during adult life. Our work provides a mechanism for how early clonal dynamics imprint the hierarchy of T cell clone sizes with implications for pathogen defense and autoimmunity. Introduction The hallmark of adaptive immunity is the generation of diversity through genetic recombination and clonal selection. Their interplay balances the breadth and specificity of the ~1012 T cells in the human *For correspondence: body (Figure 1A; Arstila et al., 1999; Farber et al., 2014): The genetic recombination of the T cell [email protected] receptor (TCR) locus, termed VDJ recombination, generates an enormous potential diversity of receptors ranging from early estimates of ~1015 (Davis and Bjorkman, 1988) to more recent esti- Competing interests: The mates of ~1061 (Mora and Walczak, 2016) different possible receptor TCRab heterodimers.
    [Show full text]
  • Advancing the Management of Plasma Cell Dyscrasias
    Advancing the Management of Plasma Cell Dyscrasias Rachid Baz, MD Moffitt Cancer Center Beth Faiman, PhD, MSN, APRN-BC, AOCN® Cleveland Clinic Learning Objectives • Interpret differential diagnoses of plasma cell dyscrasias • Assess recent changes in clinical management of the spectrum of multiple myeloma (smoldering, monoclonal gammopathy of undetermined significance [MGUS]) • Evaluate the risks and benefits of early treatments for smoldering myeloma • Plan management strategies for patients with solitary plasmacytomas and amyloidosis Financial Disclosure • Dr. Faiman has acted as a consultant and served on the speakers bureau for Amgen and Takeda; she has served on the speakers bureau for Celgene and Janssen. • Dr. Baz has received research support from AbbVie, Bristol- Myers Squibb, Celgene, Karyopharm, Merck, and Takeda; he has received honoraria from Celgene. All Blood Cells Begin as Hematopoietic Stem Cells Natural killer Healthy Bone Marrow Neutrophils (NK) cells Lymphoid progenitor T lymphocytes Basophils cell B lymphocytes Eosinophils Hematopoietic Multipotential Myeloid Monocytes/ stem cell stem cell progenitor cell macrophages Platelets Red blood cells NIH Stem Cell Information website. Based on: https://stemcells.nih.gov/info/basics/4.htm. Plasma Cell Disorders: Distribution of Plasma Cell Dyscrasias N = 1,296 SMM 3.5% (44) Lymphoproliferative Solitary or extramedullary 2.5% 1.5% AL Amyloidosis 10% Macro 3% Other 2.5% Myeloma 15% MGUS 62% AL = amyloidosis; MGUS = monoclonal gammopathy of uncertain significance; SMM = smoldering
    [Show full text]
  • Analysis of T-Cell Clones in Systemic Lupus Erythematosus
    Haematologica 2000; 85:118-123 Phagocytes & Lymphocytes original paper Analysis of T-cell clones in systemic lupus erythematosus MARCELLA CONVERSO, MARIA TIZIANA BERTERO, ANTONELLA VALLARIO, FEDERICO CALIGARIS-CAPPIO Dipartimento di Scienze Biomediche e Oncologia Umana, Università di Torino, Ospedale Mauriziano Umberto I°, Turin and Istituto per la Ricerca e la Cura del Cancro (IRCC), Candiolo, Italy ABSTRACT Background and Objectives. It is fairly well estab- nificant insight into normal T-cell function, it is now being evaluated whether pathologic conditions may lished that T-helper (TH)1 cells play a role in the pathogenesis of organ-specific autoimmune dis- be influenced by one of the two alternative polarized 2 eases, while their role and their relationship with responses. It is fairly well established that TH1 cells TH2 cells is far from being defined in systemic lupus play a role in the pathogenesis of organ-specific 1,4 erythematosus (SLE). To address this issue, six autoimmune diseases, while their role, as well as female patients who fulfilled the American Rheuma- their relationship with TH2 cells, in systemic autoim- 1 tism Association criteria for the diagnosis of SLE mune diseases is far from defined. This is especial- were studied. ly true in systemic lupus erythematosus (SLE), a mul- tifactorial systemic autoimmune disease character- Design and Methods. We analyzed the intracellular ized by abnormal immune function with increased production of cytokines by T-cells from the periph- numbers of hyperactive B-cells together with eral blood (PB). Then, we established T-cell clones impaired T-cell regulation and a dysfunction of anti- (TCC) from the peripheral blood (PB) of all cases as gen-presenting cells.5 A number of observations in well as from the synovial fluid of one patient with an murine SLE models suggest a role for TH2 cells.
    [Show full text]
  • Understanding and Interpreting Serum Protein Electrophoresis THEODORE X
    Understanding and Interpreting Serum Protein Electrophoresis THEODORE X. O’CONNELL, M.D., TIMOTHY J. HORITA, M.D., and BARSAM KASRAVI, M.D. Kaiser Permanente Woodland Hills Family Medicine Residency Program, Woodland Hills, California Serum protein electrophoresis is used to identify patients with multiple myeloma and other serum protein disorders. Electrophoresis separates proteins based on their physical proper- ties, and the subsets of these proteins are used in interpreting the results. Plasma protein levels display reasonably predictable changes in response to acute inflammation, malignancy, trauma, necrosis, infarction, burns, and chemical injury. A homogeneous spike-like peak in a focal region of the gamma-globulin zone indicates a monoclonal gammopathy. Monoclonal gammopathies are associated with a clonal process that is malignant or potentially malignant, including mul- tiple myeloma, Waldenström’s macroglobulinemia, solitary plasmacytoma, smoldering multiple myeloma, monoclonal gammopathy of undetermined significance, plasma cell leukemia, heavy chain disease, and amyloidosis. The quantity of M protein, the results of bone marrow biopsy, and other characteristics can help differentiate multiple myeloma from the other causes of monoclonal gammopathy. In contrast, polyclonal gammopathies may be caused by any reac- tive or inflammatory process. (Am Fam Physician 2005;71:105-12. Copyright© 2005 American Academy of Family Physicians.) See page 27 for levels-of- erum protein electrophoresis is a lab- Several subsets of serum protein electro- evidence definitions. oratory examination that commonly phoresis are available. The names of these is used to identify patients with mul- subsets are based on the method that is used tiple myeloma and other disorders of to separate and differentiate the various S serum protein.
    [Show full text]
  • Clonal Analysis of Untreated Non-Hodgkin's Lymphoma Utilizing Immunoglobulin Gene Rearrangement and Immunophenotype1
    [CANCER RESEARCH 48, 6272-6277, November 15, 1988] Clonal Analysis of Untreated Non-Hodgkin's Lymphoma Utilizing Immunoglobulin Gene Rearrangement and Immunophenotype1 Richard A. Rudders,2 Satinder Dhillon, and Theodore G. Krontiris Hematology/Oncology Division, Department of Medicine, and Department of Molecular Biology and Microbiology, Tufts University School of Medicine, and the New England Medical Center Hospitals, Boston, Massachusetts 02111 ABSTRACT is entirely absent. The recent development of molecular probes for genetic events associated with B-cell differentiation provides We have prospectively examined 66 consecutive initial diagnostic a potentially powerful approach for the study of lymphoma- lymph node biopsies from unselected patients suspected of having malig genesis. From the work of many investigators, it has been nant lymphoma for clonal immunophenotypic and immunogenotypic markers. By morphological and cell surface phenotypic criteria 52 had possible to determine the structure of the germ line Ig genes non-Hodgkin's lymphoma derived from the B-cell lineage and in these and construct a model of Ig gene rearrangement that is associ we compared surface immunoglobulin criteria for clonality with ¡iniiiu- ated with the maturation of B cells (1-3). Proceeding from this noglobulin gene rearrangement as detected by .In, ( ., and ( ...gene probes. scheme, several groups have shown that neoplasms of human We found that the addition of Bgl\l and ///mill I double digests to the B-cells such as leukemia and lymphoma regularly exhibit re standard /(umili and EcoRl restriction enzymes made it possible to arrangements of Ig genes that can serve as a diagnostic criterion detect rearrangement in the vast majority of lymphomas and that re for malignancy (4-8).
    [Show full text]
  • Secondary Immune Responses Memory B Cell Clone During
    Contrasting the In Situ Behavior of a Memory B Cell Clone During Primary and Secondary Immune Responses This information is current as Kalpit A. Vora, Kathleen Tumas-Brundage and Tim Manser of October 2, 2021. J Immunol 1999; 163:4315-4327; ; http://www.jimmunol.org/content/163/8/4315 References This article cites 74 articles, 31 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/163/8/4315.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 2, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1999 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Contrasting the In Situ Behavior of a Memory B Cell Clone During Primary and Secondary Immune Responses1 Kalpit A. Vora, Kathleen Tumas-Brundage, and Tim Manser2 Whether memory B cells possess altered differentiative potentials and respond in a qualitatively distinct fashion to extrinsic signals as compared with their naive precursors is a current subject of debate.
    [Show full text]
  • Serum Protein Bands
    Making Sense of Serum Protein Bands Serum protein bands (monoclonal gammopathy) will sometimes be found following serum protein electrophoresis in patients presenting with classic signs or symptoms of multiple myeloma, e.g. bone pain. In other cases, patients may have non-specific symptoms, meaning the discovery is more unexpected. Irrespective of how the band is discovered, there are additional tests that can be performed to provide more information to help with the diagnosis and to guide management. These tests include; immunofixation, Bence-Jones protein and serum free light chains. While we may recognise the names of some of the tests, it can be confusing to know the situations in which they should be requested, and even what the results mean. This article provides an overview of the clinical situations in which a patient may have a monoclonal gammopathy in their serum, what these results mean, and the role of other related laboratory tests. In a general practice setting, test results showing increased occasionally radiological findings (see “Indications for protein in serum or urine are often incidental findings requesting serum protein electrophoresis”). when investigations have been requested for other reasons. Patients with clinical conditions such as multiple Electrophoresis fractions myeloma, that increase the levels of protein in serum or urine, may present with a wide range of symptoms or Serum protein electrophoresis separates serum proteins may be asymptomatic. In these patients serum protein into the following fractions: albumin, alpha, beta and electrophoresis may have been requested as part of the gamma globulins. Approximately 60% of the total protein initial work-up.
    [Show full text]
  • Generation of Monoclonal Antibodies to a Human Natural Killer Clone
    Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. T Hercend, … , S F Schlossman, J Ritz J Clin Invest. 1985;75(3):932-943. https://doi.org/10.1172/JCI111794. Research Article The initial characterization of two monoclonal antibodies directed at antigens selectively expressed on large granular lymphocytes (LGL) is reported in the present paper. These two reagents, anti-natural killer (NK) H1A and anti-NKH2, were obtained following immunization of mouse spleen cells with a cloned human NK cell line termed JT3. In fresh human peripheral blood, both anti-NKH1A and anti-NKH2 selectively reacted with cells that appeared morphologically as large granular lymphocytes. However, complement lysis studies and two color fluorescence analysis demonstrated that some LGL express both antigens and other cells express only NKH1A or NKH2. Functional analysis of these subsets indicated that the population of NKH1A+ cells contains the entire pool of NK active lymphocytes, whereas expression of NKH2 antigen appeared to delineate a unique subpopulation of LGL which, in a resting state, display a low degree of spontaneous cytotoxicity. Expression of NKH1A and NKH2 was also investigated using a series of nine well characterized human NK clones. All NK clones were found to be NKH1A+ and four out of nine also expressed NKH2. These results strongly supported the view that NKH1A is a "pan-NK" associated antigen, and indicated that at least a fraction of cloned NKH2 + LGL are strongly cytotoxic. Anti-NKH1A was shown to have the same specificity as the previously described N901 antibody and was found here to precipitate […] Find the latest version: https://jci.me/111794/pdf Generation of Monoclonal Antibodies to a Human Natural Killer Clone Characterization of Two Natural Killer-associated Antigens, NKHIA and NKH2, Expressed on Subsets of Large Granular Lymphocytes Thierry Hercend, James D.
    [Show full text]
  • Assessment of Clonality in Human Tumors: a Review J
    [CANCER RESEARCH 50, 1355-1360, March 1, 1990] Review Assessment of Clonality in Human Tumors: A Review J. S. Wainscoat1 and M. F. Fey Department of Haematology, John Radcliffe Hospital. Oxford, United Kingdom [J.S.W.], and Institut fur Medizinische Onkologie, Inselspital, CH-3010, Bern, Switzerland [M. F. F.] Abstract "traditional" methods and those based on various types of DNA analysis. The various methods of determination of the clonali) y of human tumors Both DNA and traditional methods depend upon the dem are described. There are three major approaches based on X-chromosome onstration that a cell population is homogeneous with respect inactivation analysis, lymphocyte analysis, and somatic mutation analy to a particular marker. Since at the time of presentation tumors sis. For each of these approaches there are established methods and may have undergone extensive genetic change and continuing more recent methods based on DNA analysis. The increasing number of methods available increases the scope of clonality determination to most selection of particular subclones may have occurred, clonality tumors. All the methods have inherent advantages and disadvantages, as assessed by any of the currently available methods may still and these are discussed in relation to their clinical application. not necessarily reflect the earliest events in tumorigenesis. A tumor may have originated from several cells, the progeny of one of these cells (bearing the marker) eventually having out grown all the others (4). The clonality of human tumors has direct relevance to theo ries of carcinogenesis and has practical implications for both diagnosis and subsequent studies of disease progression. The X-Chromosome Inactivation purpose of this review is to discuss the different methods of In females inactivation of one X chromosome occurs in each clonality determination, in particular those based on DNA somatic cell in early embryonic development and is passed onto analysis, and to illustrate their use in human tumors.
    [Show full text]
  • B&T Cell Associated Lymphoma
    IHC PANEL MARKERS B&T Cell Associated Lymphoma B-cell T-cell BioGenex offers a vast spectrum of high-quality antibodies for both diagnostic and reference laboratories, with an emphasis on cancer and infectious diseases. BioGenex strives to support your efforts in clinical diagnostics and drug discovery development as we continue to expand our antibody product line offering. The following antibodies have been optimized for immunohistochemistry procedures on formalin-fixed, paraffin-embedded tissue sections. Antibodies for B&T Cell Associated Lymphoma CD45, TDT, CD15, CD30, CD19, CD79a, CD21, CD66, CD20, Kappa, Lambda, IgM, BLA.36, IgG, B Cell, IgD, Cyclin-D1, CD3, ZAP-70, PAX5, BCL2, PU.1, BOB-1, CD8, MUM1, CD138, CD5, CD10, BCL6, ALK, CD38, CD4, Ki-67, CD43, CD15, CD1a, CD71, CD7, HLA-DR, CD19, CD22, CD11c, CD56, CD68, CD10, CD23, ALK IHC PANEL MARKERS - B&T Cell Associated Lymphoma Panel CD45 CD45 (LCA) is a transmembrane protein-tyrosine-phosphatase. The LCA family includes a group of proteins present on all mature B and T lymphocytes, thymocytes, macrophages, spleen, lymph node, chronic lymphatic leukemia cells, bone marrow, thymus and granulocytes. It is absent in brain, kidney, liver, heart, erythrocytes, platelets and normal serum. The leukocyte common antigen is an abundant lymphocyte surface antigen that has been reported to be involved in signaling through the T cell antigen receptor. This antibody may be useful in the evaluation of malignant lymphoma and nonlymphoid tumors. Neoplastic B and T cells in leukemia and in non-Hodgkin’s lymphoma stain positive and hence can be distinguished from sarcomas and carcinomas.
    [Show full text]